[1]
Zahran, A.M. et al. 2026. Could the Immune Modulation of Invariant Natural Killer T Cell and the Expression of CD244 and CD196 on Natural Killer Cell Subtypes Impact the Treatment Outcomes of Acute Myeloid Leukemia Patients?. Journal of Hematology. 15, 4 (Jan. 2026), 198–213. DOI:https://doi.org/10.14740/jh2209.